Mkts

Arcturus Therapeutics Holdings Inc.

NASDAQ: ARCT
$9.68-1.35 (-12.24%)
As of Nov 2, 2:42 PM ET

Key statistics

Day range
9.6611.06
52-week range
5.5017.96
Today
Open10.94
Previous close9.68
Volume—
Valuation
Market cap313.51M
P/E ratio—
EPS (TTM)-3.31
Income & risk
Dividend / yield—
Beta2.62
Avg volume862.4K
Discussion

ARCT News

Stories mentioning ARCT from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue2,0617,19717,15128,30129,38222,76641,67349,859
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development21,52724,47523,26529,57934,89343,78039,13458,669
Sales General & Admin
Total Operating Expenses30,99238,50333,66339,91746,20856,16052,41070,985
Operating Income (Loss)(28,931)(31,306)(16,512)(11,616)(16,826)(33,394)(10,737)(21,126)
Interest Income
Interest Expense
Other Expense35.004,3153,2342,567(21.00)3,2133,8184,148
Pretax Income(29,083)(13,448)(9,176)(14,076)(30,010)(7,120)(17,366)
Tax Provision4.000.00(5.00)(217.00)(150.00)
Net Income (Loss)(26,964)(29,079)(13,448)(9,180)(14,076)(30,005)(6,903)(17,216)
Earnings Per Share (Basic)(0.95)(1.06)(0.49)(0.34)(0.52)(1.11)(0.26)(0.64)
Earnings Per Share (Diluted)(0.95)(1.06)(0.49)(0.34)(0.52)(1.11)(0.26)(0.64)
Weighted Average Shares Outstanding (Basic)28,42127,38627,18827,12927,10727,00027,06226,967
Weighted Average Shares Outstanding (Diluted)28,42127,38627,18827,12927,10727,00027,06226,967

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ARCT

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) is a stock listed on the Nasdaq Stock Market under the ticker symbol ARCT. It last traded at $9.68 (Nov 2, 2026, 2:42 PM ET), down 12.2% on the day. That gives Arcturus Therapeutics a market capitalisation of $313.5M.

Over the past 52 weeks ARCT has traded between $5.50 and $17.96.

Revenue for the quarter ended Mar 31, 2026 was $2.1M; a net loss of $27.0M. Revenue was down 93.0% from $29.4M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$2.1M-$27.0M-1308.3%
Dec 31, 2025$7.2M-$29.1M-404.0%
Sep 30, 2025$17.2M-$13.4M-78.4%
Jun 30, 2025$28.3M-$9.2M-32.4%

From Arcturus Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…